| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Notch binding | 3.30e-04 | 27 | 20 | 2 | GO:0005112 | |
| GeneOntologyCellularComponent | keratin filament | 3.14e-10 | 97 | 20 | 6 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 1.12e-09 | 227 | 20 | 7 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 3.11e-09 | 263 | 20 | 7 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 1.26e-05 | 899 | 20 | 7 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 7.22e-05 | 1179 | 20 | 7 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 7.53e-05 | 1187 | 20 | 7 | GO:0099081 |
| MousePheno | abnormal tooth color | 1.18e-05 | 40 | 16 | 3 | MP:0013129 | |
| MousePheno | hyperactivity | 1.66e-04 | 1172 | 16 | 7 | MP:0001399 | |
| MousePheno | increased thigmotaxis | 4.21e-04 | 132 | 16 | 3 | MP:0002797 | |
| MousePheno | abnormal crista ampullaris morphology | 4.56e-04 | 28 | 16 | 2 | MP:0004249 | |
| MousePheno | increased kidney weight | 5.54e-04 | 145 | 16 | 3 | MP:0003917 | |
| MousePheno | abnormal amacrine cell morphology | 5.60e-04 | 31 | 16 | 2 | MP:0005240 | |
| MousePheno | abnormal semicircular canal ampulla morphology | 5.97e-04 | 32 | 16 | 2 | MP:0008488 | |
| Domain | Keratin_B2_2 | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 7.44e-15 | 39 | 20 | 7 | PF13885 |
| Domain | KAP | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 1.44e-13 | 58 | 20 | 7 | IPR002494 |
| Domain | VWC_out | 3.67e-09 | 19 | 20 | 4 | SM00215 | |
| Domain | VWF_dom | 1.04e-07 | 42 | 20 | 4 | IPR001007 | |
| Domain | C8 | 2.98e-07 | 13 | 20 | 3 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 2.98e-07 | 13 | 20 | 3 | IPR014853 | |
| Domain | TIL_dom | 3.79e-07 | 14 | 20 | 3 | IPR002919 | |
| Domain | VWFD | 5.83e-07 | 16 | 20 | 3 | PS51233 | |
| Domain | VWD | 5.83e-07 | 16 | 20 | 3 | SM00216 | |
| Domain | VWF_type-D | 5.83e-07 | 16 | 20 | 3 | IPR001846 | |
| Domain | VWD | 5.83e-07 | 16 | 20 | 3 | PF00094 | |
| Domain | EGF | 4.02e-06 | 235 | 20 | 5 | SM00181 | |
| Domain | EGF-like_dom | 5.33e-06 | 249 | 20 | 5 | IPR000742 | |
| Domain | EGF_Lam | 6.72e-06 | 35 | 20 | 3 | SM00180 | |
| Domain | Laminin_EGF | 6.72e-06 | 35 | 20 | 3 | PF00053 | |
| Domain | VWC | 8.65e-06 | 38 | 20 | 3 | SM00214 | |
| Domain | Laminin_EGF | 8.65e-06 | 38 | 20 | 3 | IPR002049 | |
| Domain | Keratin_B2 | 1.01e-05 | 40 | 20 | 3 | PF01500 | |
| Domain | EGF_extracell | 3.46e-05 | 60 | 20 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.46e-05 | 60 | 20 | 3 | PF07974 | |
| Domain | TIL | 7.14e-05 | 12 | 20 | 2 | PF01826 | |
| Domain | C8 | 7.14e-05 | 12 | 20 | 2 | PF08742 | |
| Domain | EGF_3 | 1.01e-04 | 235 | 20 | 4 | PS50026 | |
| Domain | EGF_1 | 1.38e-04 | 255 | 20 | 4 | PS00022 | |
| Domain | EGF-like_CS | 1.51e-04 | 261 | 20 | 4 | IPR013032 | |
| Domain | EGF_2 | 1.60e-04 | 265 | 20 | 4 | PS01186 | |
| Domain | CT | 2.48e-04 | 22 | 20 | 2 | SM00041 | |
| Domain | Cys_knot_C | 3.22e-04 | 25 | 20 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.22e-04 | 25 | 20 | 2 | PS01225 | |
| Domain | hEGF | 4.05e-04 | 28 | 20 | 2 | PF12661 | |
| Domain | VWC | 4.05e-04 | 28 | 20 | 2 | PF00093 | |
| Domain | EGF_LAM_1 | 4.65e-04 | 30 | 20 | 2 | PS01248 | |
| Domain | EGF_LAM_2 | 4.65e-04 | 30 | 20 | 2 | PS50027 | |
| Domain | Growth_fac_rcpt_ | 5.87e-04 | 156 | 20 | 3 | IPR009030 | |
| Domain | VWFC_1 | 6.72e-04 | 36 | 20 | 2 | PS01208 | |
| Domain | VWFC_2 | 7.48e-04 | 38 | 20 | 2 | PS50184 | |
| Domain | EGF | 7.92e-03 | 126 | 20 | 2 | PF00008 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 2.95e-10 | 217 | 13 | 7 | M27640 |
| Pathway | REACTOME_KERATINIZATION | 2.39e-09 | 153 | 13 | 6 | MM15343 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.74e-06 | 502 | 13 | 6 | MM14537 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 JAG1 KRTAP12-3 | 8.97e-06 | 1432 | 13 | 8 | M509 |
| Pubmed | 1.85e-12 | 69 | 20 | 6 | 18721477 | ||
| Pubmed | 5.19e-09 | 37 | 20 | 4 | 11279113 | ||
| Pubmed | An ultra-high sulfur keratin gene is expressed specifically during hair growth. | 9.09e-09 | 8 | 20 | 3 | 2465353 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 24604720 | ||
| Pubmed | 4.19e-07 | 26 | 20 | 3 | 15454262 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.03e-05 | 74 | 20 | 3 | 16625196 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 15028290 | ||
| Pubmed | 7.21e-05 | 22 | 20 | 2 | 29140246 | ||
| Pubmed | Patched 1 is a crucial determinant of asymmetry and digit number in the vertebrate limb. | 7.89e-05 | 23 | 20 | 2 | 19783740 | |
| Pubmed | 1.18e-04 | 28 | 20 | 2 | 35297995 | ||
| Pubmed | Fgf10 is required for specification of non-sensory regions of the cochlear epithelium. | 1.26e-04 | 29 | 20 | 2 | 25624266 | |
| Pubmed | Sox11 gene disruption causes congenital anomalies of the kidney and urinary tract (CAKUT). | 1.45e-04 | 31 | 20 | 2 | 29459093 | |
| Pubmed | Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. | 1.45e-04 | 31 | 20 | 2 | 19898483 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.45e-04 | 31 | 20 | 2 | 31550482 | |
| Pubmed | Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development. | 1.74e-04 | 34 | 20 | 2 | 23123965 | |
| Pubmed | 1.85e-04 | 35 | 20 | 2 | 21074523 | ||
| Pubmed | 2.07e-04 | 37 | 20 | 2 | 22432025 | ||
| Pubmed | The developing mouse coronal suture at single-cell resolution. | 2.07e-04 | 37 | 20 | 2 | 34376651 | |
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 2.14e-04 | 205 | 20 | 3 | 12040188 | |
| Pubmed | 2.54e-04 | 41 | 20 | 2 | 22675208 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 4.10e-04 | 630 | 20 | 4 | 36949045 | |
| Pubmed | Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. | 4.25e-04 | 53 | 20 | 2 | 23535033 | |
| Interaction | LCE3E interactions | 2.11e-07 | 60 | 18 | 4 | int:LCE3E | |
| Interaction | LCE3C interactions | 3.30e-07 | 67 | 18 | 4 | int:LCE3C | |
| Interaction | LCE1E interactions | 3.50e-07 | 68 | 18 | 4 | int:LCE1E | |
| Interaction | LCE2A interactions | 3.71e-07 | 69 | 18 | 4 | int:LCE2A | |
| Interaction | LCE1D interactions | 3.94e-07 | 70 | 18 | 4 | int:LCE1D | |
| Interaction | LCE3D interactions | 4.66e-07 | 73 | 18 | 4 | int:LCE3D | |
| Interaction | LCE2D interactions | 4.93e-07 | 74 | 18 | 4 | int:LCE2D | |
| Interaction | LCE3A interactions | 5.49e-07 | 76 | 18 | 4 | int:LCE3A | |
| Interaction | LCE1C interactions | 5.79e-07 | 77 | 18 | 4 | int:LCE1C | |
| Interaction | ZNF837 interactions | 6.42e-07 | 79 | 18 | 4 | int:ZNF837 | |
| Interaction | SMCP interactions | 6.42e-07 | 79 | 18 | 4 | int:SMCP | |
| Interaction | LCE4A interactions | 6.75e-07 | 80 | 18 | 4 | int:LCE4A | |
| Interaction | LCE1A interactions | 8.22e-07 | 84 | 18 | 4 | int:LCE1A | |
| Interaction | LCE1B interactions | 8.62e-07 | 85 | 18 | 4 | int:LCE1B | |
| Interaction | LCE2C interactions | 9.91e-07 | 88 | 18 | 4 | int:LCE2C | |
| Interaction | LCE5A interactions | 1.08e-06 | 90 | 18 | 4 | int:LCE5A | |
| Interaction | LCE1F interactions | 1.18e-06 | 92 | 18 | 4 | int:LCE1F | |
| Interaction | KRTAP4-2 interactions | 5.01e-06 | 132 | 18 | 4 | int:KRTAP4-2 | |
| Interaction | KRTAP9-3 interactions | 6.33e-06 | 140 | 18 | 4 | int:KRTAP9-3 | |
| Interaction | KRTAP9-2 interactions | 8.10e-06 | 149 | 18 | 4 | int:KRTAP9-2 | |
| Interaction | OTX1 interactions | 9.47e-06 | 155 | 18 | 4 | int:OTX1 | |
| Interaction | CREB5 interactions | 1.18e-05 | 164 | 18 | 4 | int:CREB5 | |
| Interaction | KRTAP12-1 interactions | 2.30e-05 | 63 | 18 | 3 | int:KRTAP12-1 | |
| Interaction | CRCT1 interactions | 2.64e-05 | 66 | 18 | 3 | int:CRCT1 | |
| Interaction | KRTAP5-9 interactions | 2.74e-05 | 203 | 18 | 4 | int:KRTAP5-9 | |
| Interaction | KRTAP1-1 interactions | 3.68e-05 | 219 | 18 | 4 | int:KRTAP1-1 | |
| Interaction | ZNF80 interactions | 4.12e-05 | 11 | 18 | 2 | int:ZNF80 | |
| Interaction | NBPF19 interactions | 4.69e-05 | 233 | 18 | 4 | int:NBPF19 | |
| Interaction | KRTAP4-4 interactions | 4.89e-05 | 81 | 18 | 3 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 4.89e-05 | 81 | 18 | 3 | int:LCE2B | |
| Interaction | POU4F2 interactions | 5.26e-05 | 83 | 18 | 3 | int:POU4F2 | |
| Interaction | KRTAP10-9 interactions | 5.35e-05 | 241 | 18 | 4 | int:KRTAP10-9 | |
| Interaction | CHRD interactions | 7.62e-05 | 94 | 18 | 3 | int:CHRD | |
| Interaction | KRTAP5-6 interactions | 7.62e-05 | 94 | 18 | 3 | int:KRTAP5-6 | |
| Interaction | SHFL interactions | 8.37e-05 | 97 | 18 | 3 | int:SHFL | |
| Interaction | ZNF578 interactions | 1.02e-04 | 17 | 18 | 2 | int:ZNF578 | |
| Interaction | GNE interactions | 1.03e-04 | 104 | 18 | 3 | int:GNE | |
| Interaction | KRTAP10-7 interactions | 1.14e-04 | 293 | 18 | 4 | int:KRTAP10-7 | |
| Interaction | SPRY1 interactions | 1.25e-04 | 111 | 18 | 3 | int:SPRY1 | |
| Interaction | NKD1 interactions | 1.57e-04 | 21 | 18 | 2 | int:NKD1 | |
| Interaction | ZNF491 interactions | 1.89e-04 | 23 | 18 | 2 | int:ZNF491 | |
| Interaction | MOBP interactions | 1.89e-04 | 23 | 18 | 2 | int:MOBP | |
| Interaction | CHRNG interactions | 1.89e-04 | 23 | 18 | 2 | int:CHRNG | |
| Interaction | RSPO2 interactions | 2.06e-04 | 24 | 18 | 2 | int:RSPO2 | |
| Interaction | SPATA3 interactions | 2.06e-04 | 24 | 18 | 2 | int:SPATA3 | |
| Interaction | HOXA1 interactions | 2.41e-04 | 356 | 18 | 4 | int:HOXA1 | |
| Interaction | SLC23A1 interactions | 2.42e-04 | 26 | 18 | 2 | int:SLC23A1 | |
| Interaction | ZNF439 interactions | 2.61e-04 | 27 | 18 | 2 | int:ZNF439 | |
| Interaction | KRTAP12-3 interactions | 2.81e-04 | 146 | 18 | 3 | int:KRTAP12-3 | |
| Interaction | NOTCH2NLA interactions | 3.12e-04 | 381 | 18 | 4 | int:NOTCH2NLA | |
| Interaction | KRTAP10-1 interactions | 3.22e-04 | 153 | 18 | 3 | int:KRTAP10-1 | |
| Interaction | TNP2 interactions | 3.45e-04 | 31 | 18 | 2 | int:TNP2 | |
| Interaction | KRTAP10-5 interactions | 3.67e-04 | 160 | 18 | 3 | int:KRTAP10-5 | |
| Interaction | KRTAP10-8 interactions | 3.79e-04 | 401 | 18 | 4 | int:KRTAP10-8 | |
| Interaction | BCL6B interactions | 3.91e-04 | 33 | 18 | 2 | int:BCL6B | |
| Interaction | WNT11 interactions | 4.41e-04 | 35 | 18 | 2 | int:WNT11 | |
| Interaction | ZNF417 interactions | 5.01e-04 | 178 | 18 | 3 | int:ZNF417 | |
| Interaction | KRTAP1-3 interactions | 5.52e-04 | 184 | 18 | 3 | int:KRTAP1-3 | |
| Interaction | ZNF440 interactions | 5.76e-04 | 40 | 18 | 2 | int:ZNF440 | |
| Interaction | YY1 interactions | 6.05e-04 | 454 | 18 | 4 | int:YY1 | |
| Interaction | GLRX3 interactions | 6.16e-04 | 191 | 18 | 3 | int:GLRX3 | |
| Interaction | ZNF497 interactions | 6.97e-04 | 44 | 18 | 2 | int:ZNF497 | |
| Interaction | ZNF20 interactions | 6.97e-04 | 44 | 18 | 2 | int:ZNF20 | |
| Interaction | LCE3B interactions | 7.62e-04 | 46 | 18 | 2 | int:LCE3B | |
| Interaction | C22orf39 interactions | 8.64e-04 | 49 | 18 | 2 | int:C22orf39 | |
| Interaction | ADAMTSL4 interactions | 8.92e-04 | 217 | 18 | 3 | int:ADAMTSL4 | |
| Interaction | ZNF490 interactions | 9.00e-04 | 50 | 18 | 2 | int:ZNF490 | |
| Interaction | DHRS1 interactions | 9.36e-04 | 51 | 18 | 2 | int:DHRS1 | |
| Interaction | CYSRT1 interactions | 9.42e-04 | 511 | 18 | 4 | int:CYSRT1 | |
| Interaction | PDE9A interactions | 1.05e-03 | 54 | 18 | 2 | int:PDE9A | |
| Interaction | PRKAB2 interactions | 1.11e-03 | 234 | 18 | 3 | int:PRKAB2 | |
| Interaction | C11orf87 interactions | 1.21e-03 | 58 | 18 | 2 | int:C11orf87 | |
| Interaction | ZNF124 interactions | 1.25e-03 | 59 | 18 | 2 | int:ZNF124 | |
| Interaction | KRTAP5-2 interactions | 1.38e-03 | 62 | 18 | 2 | int:KRTAP5-2 | |
| Interaction | KRT20 interactions | 1.42e-03 | 63 | 18 | 2 | int:KRT20 | |
| Interaction | KRTAP5-4 interactions | 1.42e-03 | 63 | 18 | 2 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 1.47e-03 | 64 | 18 | 2 | int:KRTAP10-11 | |
| Interaction | NPDC1 interactions | 1.52e-03 | 65 | 18 | 2 | int:NPDC1 | |
| Interaction | KRTAP5-3 interactions | 1.56e-03 | 66 | 18 | 2 | int:KRTAP5-3 | |
| Interaction | DOCK2 interactions | 1.56e-03 | 66 | 18 | 2 | int:DOCK2 | |
| Interaction | NR1D2 interactions | 1.61e-03 | 67 | 18 | 2 | int:NR1D2 | |
| Interaction | ZNF696 interactions | 1.66e-03 | 68 | 18 | 2 | int:ZNF696 | |
| Interaction | ZNF835 interactions | 1.71e-03 | 69 | 18 | 2 | int:ZNF835 | |
| Interaction | KRTAP5-7 interactions | 1.81e-03 | 71 | 18 | 2 | int:KRTAP5-7 | |
| Interaction | VGLL3 interactions | 1.86e-03 | 72 | 18 | 2 | int:VGLL3 | |
| Interaction | CHIC2 interactions | 1.91e-03 | 73 | 18 | 2 | int:CHIC2 | |
| Interaction | KPRP interactions | 1.93e-03 | 284 | 18 | 3 | int:KPRP | |
| Interaction | MAPKBP1 interactions | 1.96e-03 | 74 | 18 | 2 | int:MAPKBP1 | |
| Interaction | KRTAP4-5 interactions | 2.06e-03 | 76 | 18 | 2 | int:KRTAP4-5 | |
| Interaction | ZNF774 interactions | 2.23e-03 | 79 | 18 | 2 | int:ZNF774 | |
| Interaction | BMP7 interactions | 2.28e-03 | 80 | 18 | 2 | int:BMP7 | |
| Interaction | GUCD1 interactions | 2.76e-03 | 88 | 18 | 2 | int:GUCD1 | |
| Interaction | TFAP2D interactions | 2.82e-03 | 89 | 18 | 2 | int:TFAP2D | |
| Interaction | MEOX2 interactions | 2.95e-03 | 697 | 18 | 4 | int:MEOX2 | |
| Interaction | FAM76B interactions | 3.47e-03 | 99 | 18 | 2 | int:FAM76B | |
| Interaction | KRTAP13-2 interactions | 3.47e-03 | 99 | 18 | 2 | int:KRTAP13-2 | |
| Interaction | KRTAP9-8 interactions | 3.54e-03 | 100 | 18 | 2 | int:KRTAP9-8 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 4.73e-05 | 473 | 20 | 4 | chr17q21 | |
| Cytoband | 17q12-q21 | 8.87e-05 | 32 | 20 | 2 | 17q12-q21 | |
| Cytoband | 17q21.2 | 4.28e-04 | 70 | 20 | 2 | 17q21.2 | |
| Cytoband | 11p15.5 | 1.21e-03 | 118 | 20 | 2 | 11p15.5 | |
| Cytoband | 21q22.3 | 1.42e-03 | 128 | 20 | 2 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.80e-03 | 564 | 20 | 3 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 1.16e-02 | 377 | 20 | 2 | chr21q22 | |
| GeneFamily | Keratin associated proteins | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 2.60e-12 | 109 | 16 | 7 | 619 |
| Coexpression | NABA_MATRISOME | 7.77e-05 | 1008 | 20 | 6 | MM17056 | |
| Coexpression | NABA_MATRISOME | 8.57e-05 | 1026 | 20 | 6 | M5889 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP9-7 KRTAP9-6 KRTAP4-5 KRTAP5-5 KRTAP10-9 KRTAP9-1 KRTAP12-3 | 2.45e-13 | 146 | 20 | 7 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.74e-06 | 200 | 20 | 4 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-05 | 167 | 20 | 3 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.97e-05 | 172 | 20 | 3 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 180 | 20 | 3 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 180 | 20 | 3 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-05 | 183 | 20 | 3 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 184 | 20 | 3 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 184 | 20 | 3 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 185 | 20 | 3 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 185 | 20 | 3 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 185 | 20 | 3 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 185 | 20 | 3 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 185 | 20 | 3 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-05 | 186 | 20 | 3 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 187 | 20 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 187 | 20 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 191 | 20 | 3 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 191 | 20 | 3 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 191 | 20 | 3 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.40e-05 | 193 | 20 | 3 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.40e-05 | 193 | 20 | 3 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.40e-05 | 193 | 20 | 3 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 18-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 8.66e-05 | 195 | 20 | 3 | e0ee7905499ee1a1ca7b1184e2713028cf156985 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 195 | 20 | 3 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-05 | 197 | 20 | 3 | 1c91e3afcc5be195b827a1dff83aff5cc2492456 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.92e-05 | 197 | 20 | 3 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.19e-05 | 199 | 20 | 3 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Macroglial|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.33e-05 | 200 | 20 | 3 | bda719369aa199902789061e223b129f70a1317a | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.18e-04 | 95 | 20 | 2 | 53dde5363ea1d64386234e5bd4fbb28c057f2f21 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.18e-04 | 95 | 20 | 2 | ef0b7289b348617a76b4643479adc7e9701c0094 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.18e-04 | 95 | 20 | 2 | 8b4d6b25ce28811a76ea11713d881117e495ef5e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-1|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.35e-04 | 96 | 20 | 2 | 14cad3fae85e41b9f629b8a81a433b652276930c | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 107 | 20 | 2 | 2f84089acc794b43ee59452dc8f90ca7261ebd41 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 107 | 20 | 2 | 0b45241cc52d10225966b49941efb66997184158 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 107 | 20 | 2 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 107 | 20 | 2 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.09e-03 | 110 | 20 | 2 | ebf871bf29796caf25dd83a587774efe7f7c79ec | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 115 | 20 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 115 | 20 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 115 | 20 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.36e-03 | 123 | 20 | 2 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.43e-03 | 126 | 20 | 2 | b0bc61be1d4ce8114077c524fedfdf89128bcf12 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.50e-03 | 129 | 20 | 2 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-03 | 132 | 20 | 2 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(3)_72hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.59e-03 | 133 | 20 | 2 | 32c6a00671af309c4b0b90e93549733729684c61 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.62e-03 | 134 | 20 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.62e-03 | 134 | 20 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.64e-03 | 135 | 20 | 2 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.79e-03 | 141 | 20 | 2 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-03 | 144 | 20 | 2 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-03 | 145 | 20 | 2 | 9b69bfdbf91ef197b4c483617aa67498d9d2cd79 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-03 | 145 | 20 | 2 | 76f0cde9acdc3ad5948c007dccf312665972c9e6 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-03 | 145 | 20 | 2 | 31af9fce1dcd7e8ae1604476598e099232017ee9 | |
| ToppCell | severe_influenza-Treg|World / disease group, cell group and cell class (v2) | 1.99e-03 | 149 | 20 | 2 | 2a3a00cdf604c8f3f3863df0ddb06938549bf86d | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.02e-03 | 150 | 20 | 2 | bcb99c6fa81052556ab30f9db5875fccf1ae724b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-03 | 150 | 20 | 2 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-03 | 151 | 20 | 2 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-03 | 153 | 20 | 2 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | severe_influenza-Treg|severe_influenza / disease group, cell group and cell class (v2) | 2.12e-03 | 154 | 20 | 2 | 25f74dfb0f0e014a232bc5318928c478480b178d | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.12e-03 | 154 | 20 | 2 | afdc385397c7b13c9348eeef95f109f2363057ae | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.15e-03 | 155 | 20 | 2 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-03 | 156 | 20 | 2 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-03 | 156 | 20 | 2 | e6798d2b9c2c1fc6525c24f596f25aa85a375651 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-03 | 157 | 20 | 2 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | Hippocampus-Endothelial-MURAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 158 | 20 | 2 | 2d73b5e59c650c603fec6223b1c51f0962f7bc81 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 158 | 20 | 2 | 7f4a644534b78f7e7539cae1fd895dad6f96862b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-03 | 158 | 20 | 2 | 4d997efc36fd8946775fe74dd9ac9ccd5ade64ff | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.26e-03 | 159 | 20 | 2 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 2.26e-03 | 159 | 20 | 2 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-03 | 160 | 20 | 2 | 6215ac6123a295f3c2f033786602a57b2e2e1177 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 2.29e-03 | 160 | 20 | 2 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-03 | 161 | 20 | 2 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-03 | 162 | 20 | 2 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-03 | 162 | 20 | 2 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-03 | 162 | 20 | 2 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 2.37e-03 | 163 | 20 | 2 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-03 | 164 | 20 | 2 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.40e-03 | 164 | 20 | 2 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| Disease | femoral neck bone mineral density | 4.95e-03 | 196 | 16 | 2 | EFO_0007785 | |
| Disease | diverticular disease | 7.10e-03 | 236 | 16 | 2 | EFO_0009959 | |
| Disease | asthma, response to diisocyanate | 8.62e-03 | 261 | 16 | 2 | EFO_0006995, MONDO_0004979 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPCSQCPSGYHCKNS | 181 | Q6UXB8 | |
| FCCNYGHCPSTPATS | 4221 | Q9HC84 | |
| CSLPCYCKNGASCSP | 581 | Q96KG7 | |
| EGCDASCCSPSCYSS | 671 | Q76N89 | |
| TCPPENCSGYCTCSH | 981 | O75882 | |
| NCSGYCTCSHCLEQP | 986 | O75882 | |
| GVGCLCPSQCTCDYH | 16 | Q3SXY7 | |
| CAKTVQPGCSCYHCS | 6 | Q96Q40 | |
| CQSVCYQPTCCHPSC | 46 | Q9BYR2 | |
| YQPTCCHPSCCISSC | 51 | Q9BYR2 | |
| SGCGSSCCQSSCYKP | 206 | Q701N2 | |
| YQPACCASSSCQPAC | 126 | P60411 | |
| QPTCCIHSPCQASCY | 11 | P60328 | |
| GSSCCQPCCHPTCYQ | 111 | A8MXZ3 | |
| SCCVSSCCQPYCHPT | 41 | A8MVA2 | |
| SCCQPYCHPTCCQNT | 46 | A8MVA2 | |
| CSTPCYQPICCGSSC | 81 | A8MVA2 | |
| CGSSCCQPSSCAPIY | 96 | A8MTY7 | |
| CSPHPCYNSGTCVDG | 786 | P78504 | |
| TYNECIACCPASCHP | 426 | Q6ZRI0 | |
| PPGACCPSCDSCTYH | 476 | Q6ZWJ8 | |
| HSCTCPYDQSSCQGP | 441 | Q9C0B6 | |
| CTCVTCCSGPHPNYP | 41 | Q6XCG6 | |
| YSDNPCSCSQSHCCS | 241 | O43609 | |
| YASCVPCTCNQHGTC | 701 | Q9Y6N6 |